Who
MarDee Haring-Layton
Chief Accounting Officer
Company insider
Files Form 4 as: Chief Accounting Officer, Dare Bioscience; Chief Financial Officer, E Digital.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 5 Dec 2011
- Last trade
- 30 Jan 2026
- Last filed
- 2 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jan 2026filed 2 Feb 2026 | DARE Dare Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —49,000 at $0.00 | filing |
| 30 Jan 2026filed 2 Feb 2026 | DARE Dare Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —49,000 at $0.00 | filing |
| 4 Sep 2025filed 4 Sep 2025 | DARE Dare Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —57,000 at $0.00 | filing |
| 28 Jan 2025filed 31 Jan 2025 | DARE Dare Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,000 at $0.00 | filing |
| 12 Mar 2024filed 14 Mar 2024 | DARE Dare Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —290,000 at $0.00 | filing |
| 30 Mar 2015filed 31 Mar 2015 | E Digitaloption or derivative | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 25 Mar 2014filed 26 Mar 2014 | E Digitaloption or derivative | SEC FORM 4 Code A | —410,000 at $0.00 | filing |
| 5 Dec 2011filed 7 Dec 2011 | E Digitaloption or derivative | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.